1. Home
  2. PDLB vs EBS Comparison

PDLB vs EBS Comparison

Compare PDLB & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.65

Market Cap

405.9M

Sector

N/A

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.21

Market Cap

434.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
EBS
Founded
1960
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.9M
434.4M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
PDLB
EBS
Price
$16.65
$8.21
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
63.2K
1.1M
Earning Date
04-24-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
125.83
EPS
1.20
0.93
Revenue
N/A
$742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
$13.88
$8.62
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$4.02
52 Week High
$18.01
$14.06

Technical Indicators

Market Signals
Indicator
PDLB
EBS
Relative Strength Index (RSI) 56.18 36.43
Support Level $15.84 $7.66
Resistance Level $17.29 $9.28
Average True Range (ATR) 0.35 0.30
MACD 0.04 0.08
Stochastic Oscillator 65.77 50.00

Price Performance

Historical Comparison
PDLB
EBS

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: